Has Kathleen Mendheim received payments from drug or device companies?

Yes. Drug and device makers reported $8,751 in general payments to Kathleen Mendheim across 452 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kathleen Mendheim did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kathleen Mendheim come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kathleen Mendheim

Nurse Practitioner · Dothan, ALNPI 1174873772

Payments from drug & device makers

$8,751in general payments, 2019–2025

Across 452 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$881
Incyte Corporation$763
Bristol Myers Squibb$438
AstraZeneca$425
Amgen$364
Genentech USA, Inc.$333
plus $5K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	47	$881
Incyte Corporation	30	$763
Bristol Myers Squibb	23	$438
AstraZeneca(2 entities)	24	$425
Amgen	24	$364
Genentech USA, Inc.	17	$333
Lilly USA, LLC	18	$322
Johnson & Johnson	18	$316
Takeda Pharmaceuticals U.S.A., Inc.	13	$310
Merck	16	$310
Pfizer	23	$303
AbbVie	11	$271
Exelixis Inc.	13	$237
E.r. Squibb & Sons, L.L.C.	12	$228
Sanofi	9	$203
Beigene USA, Inc.	11	$187
Regeneron Healthcare Solutions, Inc.	7	$181
Array Biopharma Inc	14	$177
Daiichi Sankyo Inc.	8	$170
Deciphera Pharmaceuticals Inc.	8	$168
Astellas Pharma US Inc	9	$137
Taiho Oncology, Inc.	2	$133
Ipsen Biopharmaceuticals, Inc	6	$126
Myriad Genetic Laboratories, Inc.	2	$116
Eisai Inc.	5	$99
GSK	6	$91
Seagen Inc.	5	$74
Puma Biotechnology, Inc.	4	$73
Pharmaessentia USA Corporation	3	$70
Beone Medicines USA, Inc.	3	$69
Coherus Oncology, Inc.	3	$68
AVEO Pharmaceuticals, Inc.	3	$64
Bayer	3	$55
Pharmacosmos Therapeutics Inc.	3	$55
ADC Therapeutics America, Inc.	3	$53
Blueprint Medicines Corporation	3	$52
Genmab U.S., Inc.	3	$48
Eagle Pharmaceuticals, Inc.	1	$47
Boehringer Ingelheim	2	$45
Acceleron Pharma, Inc.	2	$39
G1 Therapeutics, Inc.	2	$38
Servier Pharmaceuticals LLC	2	$37
Epizyme, Inc.	2	$36
Sobi, Inc	2	$36
HEMA Biologics, LLC	2	$34
Rigel Pharmaceuticals, Inc.	2	$32
Geron Corporation	1	$31
Karyopharm Therapeutics Inc.	2	$30
Morphosys, US Inc.	2	$30
Sumitomo Pharma America, Inc.	2	$30
Immunogen, Inc.	1	$25
Jazz Pharmaceuticals Inc.	1	$25
Kyowa Kirin, Inc.	1	$24
Gilead	1	$23
Agios Pharmaceuticals, Inc.	1	$22
EMD Serono, Inc.	1	$22
Tersera Therapeutics LLC	1	$22
Progenics Pharmaceuticals, Inc.	1	$21
Spectrum Pharmaceuticals Inc.	1	$21
Amneal Pharmaceuticals LLC	1	$19

How this compares

$8,751 in reported general payments places this provider in the 95th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama →

Medicare billing

Part B allowed, 2024

$34,484

Medicare patients

223

Services billed

332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Dothan

Hollie CrutchfieldDothan$22K
Christina BellDothan$14K
Shea CalhounDothan$14K
Amanda PybusDothan$13K
Tami CaldwellDothan$13K
Alison HallDothan$12K
Jennifer ParrishDothan$12K
Amanda SewellDothan$11K
Amy EthridgeDothan$11K
Allison McAllisterDothan$10K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →